WO2016017528A1 - 樹脂成形体 - Google Patents
樹脂成形体 Download PDFInfo
- Publication number
- WO2016017528A1 WO2016017528A1 PCT/JP2015/071003 JP2015071003W WO2016017528A1 WO 2016017528 A1 WO2016017528 A1 WO 2016017528A1 JP 2015071003 W JP2015071003 W JP 2015071003W WO 2016017528 A1 WO2016017528 A1 WO 2016017528A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- resin
- thermoplastic elastomer
- cyclic olefin
- styrene
- resin composition
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
- C08L65/00—Compositions of macromolecular compounds obtained by reactions forming a carbon-to-carbon link in the main chain; Compositions of derivatives of such polymers
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
- C08F32/00—Homopolymers and copolymers of cyclic compounds having no unsaturated aliphatic radicals in a side chain, and having one or more carbon-to-carbon double bonds in a carbocyclic ring system
- C08F32/08—Homopolymers and copolymers of cyclic compounds having no unsaturated aliphatic radicals in a side chain, and having one or more carbon-to-carbon double bonds in a carbocyclic ring system having two condensed rings
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
- C08J5/00—Manufacture of articles or shaped materials containing macromolecular substances
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
- C08L45/00—Compositions of homopolymers or copolymers of compounds having no unsaturated aliphatic radicals in side chain, and having one or more carbon-to-carbon double bonds in a carbocyclic or in a heterocyclic ring system; Compositions of derivatives of such polymers
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
- C08L53/00—Compositions of block copolymers containing at least one sequence of a polymer obtained by reactions only involving carbon-to-carbon unsaturated bonds; Compositions of derivatives of such polymers
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
- C08L53/00—Compositions of block copolymers containing at least one sequence of a polymer obtained by reactions only involving carbon-to-carbon unsaturated bonds; Compositions of derivatives of such polymers
- C08L53/02—Compositions of block copolymers containing at least one sequence of a polymer obtained by reactions only involving carbon-to-carbon unsaturated bonds; Compositions of derivatives of such polymers of vinyl-aromatic monomers and conjugated dienes
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G2261/00—Macromolecular compounds obtained by reactions forming a carbon-to-carbon link in the main chain of the macromolecule
- C08G2261/30—Monomer units or repeat units incorporating structural elements in the main chain
- C08G2261/33—Monomer units or repeat units incorporating structural elements in the main chain incorporating non-aromatic structural elements in the main chain
- C08G2261/332—Monomer units or repeat units incorporating structural elements in the main chain incorporating non-aromatic structural elements in the main chain containing only carbon atoms
- C08G2261/3325—Monomer units or repeat units incorporating structural elements in the main chain incorporating non-aromatic structural elements in the main chain containing only carbon atoms derived from other polycyclic systems
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G2261/00—Macromolecular compounds obtained by reactions forming a carbon-to-carbon link in the main chain of the macromolecule
- C08G2261/40—Polymerisation processes
- C08G2261/41—Organometallic coupling reactions
- C08G2261/418—Ring opening metathesis polymerisation [ROMP]
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G2261/00—Macromolecular compounds obtained by reactions forming a carbon-to-carbon link in the main chain of the macromolecule
- C08G2261/50—Physical properties
- C08G2261/59—Stability
- C08G2261/598—Chemical stability
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G2261/00—Macromolecular compounds obtained by reactions forming a carbon-to-carbon link in the main chain of the macromolecule
- C08G2261/50—Physical properties
- C08G2261/62—Mechanical aspects
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G2261/00—Macromolecular compounds obtained by reactions forming a carbon-to-carbon link in the main chain of the macromolecule
- C08G2261/70—Post-treatment
- C08G2261/72—Derivatisation
- C08G2261/724—Hydrogenation
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
- C08J2347/00—Characterised by the use of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, at least one having two or more carbon-to-carbon double bonds; Derivatives of such polymers
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
- C08J2365/00—Characterised by the use of macromolecular compounds obtained by reactions forming a carbon-to-carbon link in the main chain; Derivatives of such polymers
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
- C08J2447/00—Characterised by the use of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, at least one having two or more carbon-to-carbon double bonds; Derivatives of such polymers
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
- C08J2465/00—Characterised by the use of macromolecular compounds obtained by reactions forming a carbon-to-carbon link in the main chain; Derivatives of such polymers
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
- C08L2203/00—Applications
- C08L2203/02—Applications for biomedical use
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
- C08L2207/00—Properties characterising the ingredient of the composition
- C08L2207/04—Thermoplastic elastomer
Definitions
- the present invention relates to a resin molded article excellent in transparency, impact resistance and oil resistance.
- plastic containers and medical instruments made of synthetic resin are light in weight and can be safely and efficiently disposed of by incineration after use, so that they are widely used in place of conventional glass products. It is coming.
- Pharmaceutical containers and medical instruments may be small or have complex shapes. Also, they are often discarded without being reused after use. Therefore, as a manufacturing raw material used for manufacturing a pharmaceutical container or a medical instrument, a material that is excellent in moldability and capable of manufacturing a product of a certain quality in a large quantity and at low cost is preferable.
- the cyclic olefin resin is considered to be suitable as a raw material for producing pharmaceutical containers and medical instruments because it is excellent in transparency, low hygroscopicity, heat resistance, chemical resistance and the like.
- the cyclic olefin resin generally has high rigidity
- the conventional cyclic olefin resin product has a problem that it is easily inferior in impact resistance and durability to steam sterilization treatment.
- Patent Document 1 discloses a norbornene resin composition composed of a norbornene resin and an aromatic vinyl / conjugated diene elastomer, a packaging sheet obtained using the resin composition, and the like.
- Patent Document 2 describes a film obtained by thinning a resin composition comprising a cyclic olefin resin and a styrene elastomer. Furthermore, these documents also describe that the obtained resin molding is excellent in transparency, impact resistance and the like.
- Patent Documents 1 and 2 it is known that impact resistance can be improved while maintaining excellent transparency by blending a cyclic olefin resin with a styrene elastomer.
- pharmaceutical containers and medical instruments obtained using the resin compositions described in these documents cannot be said to sufficiently satisfy the target required performance.
- the present invention has been made in view of the above-described conventional technology, and an object thereof is to provide a resin molded article excellent in all of transparency, impact resistance and oil resistance.
- the present inventors diligently investigated a resin molded body obtained by molding a resin composition containing a cyclic olefin resin and a styrene-based thermoplastic elastomer.
- a resin composition appropriately combining a cyclic olefin resin and a styrene thermoplastic elastomer having a specific range of weight average molecular weight and a small difference in refractive index ( ⁇ nD) from the cyclic olefin resin.
- the resin molded body obtained by molding was found to be excellent in all of transparency, impact resistance and oil resistance, and the present invention was completed.
- a resin molded body obtained by molding a resin composition containing a cyclic olefin resin and a styrene-based thermoplastic elastomer,
- the styrenic thermoplastic elastomer has a weight average molecular weight (Mw) of 20,000 to 150,000, and a refractive index difference ( ⁇ nD) with respect to the refractive index of the cyclic olefin resin is more than ⁇ 0.002 + 0.00.
- the residue is 0.10% by weight or less
- the resin composition is molded into a sheet having a thickness of 3.0 mm and the light transmittance is measured using this, the light transmittance of light having a wavelength of 450 nm (light path length 3 mm) is 55%.
- the resin composition is molded into a shape of 4.0 mm thickness ⁇ 80.0 mm length ⁇ 10.0 mm width, and a notched Charpy impact test specified in JIS K7111-1 is used at 23 ° C.
- a resin molded product having a Charpy impact strength of 5 to 40 kJ / m 2 when performed.
- the styrene-based thermoplastic elastomer is a block (A) composed of a repeating unit derived from a styrene-based monomer, a block (B1) composed of a repeating unit derived from isobutylene, or a repeating unit derived from a conjugated diene monomer.
- the content ratio of the cyclic olefin resin and the styrene thermoplastic elastomer in the resin composition is 98: 2 to 40:60 in a weight ratio (cyclic olefin resin: styrene thermoplastic elastomer). [1] or [2].
- a resin molded article excellent in all of transparency, impact resistance and oil resistance is provided.
- the resin molded article of the present invention is a resin molded article obtained by molding a resin composition containing a cyclic olefin resin and a styrene-based thermoplastic elastomer, and includes the following (i), (ii), ( It is characterized by satisfying iii) and (iv).
- the styrene-based thermoplastic elastomer has a weight average molecular weight (Mw) of 20,000 to 150,000, and a refractive index difference ( ⁇ nD) from the refractive index of the cyclic olefin resin is ⁇ 0.002.
- the cyclic olefin resin used in the present invention is a polymer having an alicyclic structure in the molecule, and is a polymer obtained by performing a polymerization reaction using a cyclic olefin as a monomer or a hydride thereof.
- Examples of the alicyclic structure of the cyclic olefin resin include a cycloalkane structure and a cycloalkene structure. Among these, a cycloalkane structure is preferable because a resin molded body excellent in light resistance, durability and the like can be easily obtained.
- the number of carbon atoms constituting the alicyclic structure is not particularly limited, but is usually 4 to 30, preferably 5 to 20, and more preferably 5 to 15.
- the weight average molecular weight (Mw) of the cyclocyclic olefin resin is preferably 20,000 to 100,000, more preferably 25,000 to 50,000. If the weight average molecular weight (Mw) of the cyclic olefin resin is too small, the strength of the resin molded product may be reduced. On the other hand, if the weight average molecular weight (Mw) of the cyclic olefin resin is too large, the compatibility between the cyclic olefin resin and the styrene-based thermoplastic elastomer may be lowered.
- the molecular weight distribution (Mw / Mn) of the cyclic olefin resin is not particularly limited, but is preferably 1 to 5, more preferably 1 to 4. When the molecular weight distribution of the cyclic olefin resin is within the above range, a resin molded article having sufficient mechanical strength can be obtained.
- the weight average molecular weight (Mw) and the number average molecular weight (Mn) of the cyclic olefin resin are standard polyisoprene conversion values by gel permeation chromatography (GPC) using cyclohexane as an eluent.
- the refractive index of the cyclic olefin resin is usually 1.500 to 1.600, preferably 1.530 to 1.550.
- the refractive index means a value measured by irradiating light having a wavelength of 587.6 nm at 25 ° C.
- the difference ( ⁇ nD) between the refractive index of the cyclic olefin resin and the refractive index of the styrene-based thermoplastic elastomer can be reduced more easily.
- the refractive index of the cyclic olefin resin tends to be affected by the number of rings contained in the molecule.
- a cyclic olefin monomer used for the synthesis of a cyclic olefin resin is a monomer containing many rings such as a tricyclic monomer or a tetracyclic monomer as described later, the refractive index is It becomes easy to obtain a high cyclic olefin resin.
- the cyclic olefin resin used in the present invention includes a ring-opening polymer of a cyclic olefin monomer (hereinafter sometimes referred to as “polymer ( ⁇ )”), a hydride thereof, and a cyclic olefin monomer. Examples thereof include a polymer (hereinafter sometimes referred to as “polymer ( ⁇ )”) and a hydride thereof.
- a hydride of the polymer ( ⁇ ) is preferable because various properties are excellent in a balanced manner and a desired resin molded product is easily obtained.
- the cyclic olefin monomer used for the production of the polymer ( ⁇ ) and its hydride has a ring structure formed of carbon atoms, and carbon is contained in the ring. -A compound having a carbon double bond. Specific examples include norbornene monomers. Moreover, when a polymer ((alpha)) is a copolymer, a monocyclic cyclic olefin can also be used as a cyclic olefin monomer.
- the norbornene monomer is a monomer containing a norbornene ring.
- the norbornene-based monomer includes bicyclo [2.2.1] hept-2-ene (common name: norbornene), 5-ethylidene-bicyclo [2.2.1] hept-2-ene (common name: ethylidene).
- Bicyclic monomers such as norbornene) and derivatives thereof (having substituents in the ring); tricyclo [4.3.0.1 2,5 ] deca-3,7-diene (common name: dicyclopentadiene) And tricyclic monomers such as derivatives thereof; 7,8-tricyclo [4.3.0.1 2, 5] dec-3-ene (common name: methanolate tetrahydrofluorene, tetracyclo [7.4.0.0 2,7 .1 10,13] Trideca-2,4,6,11-tetraene) and its derivatives, tetracyclo [4.4.0.1 2,5 .
- dodec-3-ene (common name: tetracyclododecene), 8-ethylidenetetracyclo [4.4.0.1 2,5 . 1 7,10 ] -3-dodecene and its derivatives, and the like;
- These monomers may have a substituent at an arbitrary position.
- substituents include: alkyl groups such as methyl and ethyl groups; alkenyl groups such as vinyl groups; alkylidene groups such as propane-2-ylidene; aryl groups such as phenyl groups; hydroxy groups; acid anhydride groups; An alkoxycarbonyl group such as a methoxycarbonyl group;
- Examples of the monocyclic olefin include cyclomonoolefins such as cyclobutene, cyclopentene, methylcyclopentene, cyclohexene, methylcyclohexene, cycloheptene, and cyclooctene; cyclohexadiene, methylcyclohexadiene, cyclooctadiene, methylcyclooctadiene, phenylcyclooctadiene Cyclic diolefins such as; and the like.
- cyclomonoolefins such as cyclobutene, cyclopentene, methylcyclopentene, cyclohexene, methylcyclohexene, cycloheptene, and cyclooctene
- cyclohexadiene methylcyclohexadiene
- cyclooctadiene methylcyclooctadiene
- cyclic olefin monomers can be used alone or in combination of two or more.
- the polymer ( ⁇ ) may be a block copolymer or a random copolymer.
- the cyclic olefin monomer tricyclo [4.3.0.1 2,5 ] deca-3,7-diene, 8-methyl-tetracyclo [4.4.0.1 2,5 . 1 7,10 ] dodec-3-ene, tetracyclo [7.4.0.0 2,7 . 1 10, 13] trideca -2,4,6,11- tetraene is preferable.
- the polymer ( ⁇ ) can be produced according to a known method using a metathesis polymerization catalyst.
- the metathesis polymerization catalyst is not particularly limited and known ones are used.
- a metathesis polymerization catalyst a catalyst system comprising a metal halide, nitrate or acetylacetone compound selected from ruthenium, rhodium, palladium, osmium, iridium and platinum and a reducing agent; from titanium, vanadium, zirconium, tungsten and molybdenum
- a catalyst system comprising a selected metal halide or acetylacetone compound and a co-catalyst organoaluminum compound; a Schrock-type or Grubbs-type living ring-opening metathesis polymerization catalyst (JP-A-7-179575, J.
- the amount of the metathesis polymerization catalyst used may be appropriately selected depending on the polymerization conditions and the like, but is usually 0.000001 to 0.1 mol, preferably 0.00001 to 0.01 mol per mol of the cyclic olefin monomer. Is a mole.
- a linear ⁇ -olefin having 4 to 40 carbon atoms such as 1-butene, 1-hexene, 1-decene and the like can be used as a molecular weight regulator.
- the addition amount of the linear ⁇ -olefin is usually 0.001 to 0.030 mol, preferably 0.003 to 0.020 mol, more preferably 0.005 to 0, per 1 mol of the cyclic olefin monomer. .015 mole.
- Ring-opening polymerization of the cyclocyclic olefin monomer can be performed in an organic solvent.
- the organic solvent is not particularly limited as long as it is inert to the polymerization reaction.
- aromatic hydrocarbon solvents such as benzene, toluene and xylene
- aliphatic hydrocarbon solvents such as n-pentane, n-hexane and n-heptane
- alicyclic carbonization such as cyclohexane, methylcyclohexane, decalin and bicyclononane
- hydrogenated solvents halogenated hydrocarbon solvents such as dichloroethane, chlorobenzene, dichlorobenzene, and trichlorobenzene; and mixed solvents composed of two or more of these.
- the polymerization temperature is not particularly limited, but is usually ⁇ 50 to 250 ° C., preferably ⁇ 30 to 200 ° C., and more preferably ⁇ 20 to 150 ° C.
- the polymerization time is appropriately selected depending on the polymerization conditions, but is usually 30 minutes to 20 hours, preferably 1 to 10 hours.
- a hydride of the polymer ( ⁇ ) can be obtained by subjecting the polymer ( ⁇ ) obtained by the above method to a hydrogenation reaction.
- the hydrogenation reaction of the polymer ( ⁇ ) can be performed by bringing the polymer ( ⁇ ) into contact with hydrogen in the presence of a hydrogenation catalyst according to a conventional method.
- the hydrogenation catalyst may be a homogeneous catalyst or a heterogeneous catalyst.
- the homogeneous catalyst can be easily dispersed in the hydrogenation reaction solution, so that the amount of catalyst added can be suppressed.
- the polymer ( ⁇ ) and its hydride are not easily decomposed or gelled because they have sufficient activity even without high temperature and pressure. For this reason, it is selected from the viewpoint of cost and product quality.
- the heterogeneous catalyst exhibits particularly excellent activity under high temperature and high pressure, so that the polymer ( ⁇ ) can be hydrogenated in a short time. Further, the catalyst residue can be efficiently removed after the hydrogenation reaction.
- Wilkinson complex chlorotris (triphenylphosphine) rhodium (I)]; cobalt acetate / triethylaluminum, nickel acetylacetonate / triisobutylaluminum, titanocene dichloride / n-butyllithium, zirconocene dichloride / sec-butyl
- a catalyst comprising a combination of a transition metal compound and an alkyl metal compound, such as a combination of lithium, tetrabutoxytitanate / dimethylmagnesium, and the like.
- heterogeneous catalyst examples include those in which a metal such as Ni, Pd, Pt, Ru, Rh is supported on a support.
- a metal such as Ni, Pd, Pt, Ru, Rh
- an adsorbent such as alumina or diatomaceous earth as the carrier.
- the hydrogenation reaction is usually performed in an organic solvent.
- the organic solvent is not particularly limited as long as it is inert to the hydrogenation reaction.
- a hydrocarbon solvent is usually used because it easily dissolves the hydride produced.
- hydrocarbon solvents include aromatic hydrocarbon solvents such as benzene, toluene, and xylene; aliphatic hydrocarbon solvents such as n-pentane, n-hexane, and n-heptane; cyclohexane, methylcyclohexane, decalin, and bicyclononane. Alicyclic hydrocarbon-based solvents; and the like. These organic solvents can be used alone or in combination of two or more.
- the solvent used in the ring-opening polymerization reaction is also suitable as a solvent for the hydrogenation reaction. Therefore, after adding a hydrogenation catalyst to the ring-opening polymerization reaction solution, it can be used for the hydrogenation reaction.
- the hydrogenation rate varies depending on the type of hydrogenation catalyst and the reaction temperature. Therefore, when the polymer ( ⁇ ) has an aromatic ring, the residual ratio of the aromatic ring can be controlled by selecting a hydrogenation catalyst, adjusting the reaction temperature, or the like. For example, in order to leave an unsaturated bond in the aromatic ring more than a certain amount, control such as lowering the reaction temperature, lowering the hydrogen pressure, or shortening the reaction time may be performed.
- the catalyst residue can be removed by carrying out treatment such as centrifugation and filtration. If necessary, a catalyst deactivator such as water or alcohol may be used, or an adsorbent such as activated clay or alumina may be added.
- a catalyst deactivator such as water or alcohol may be used, or an adsorbent such as activated clay or alumina may be added.
- Other monomers include ⁇ -olefins having 2 to 20 carbon atoms such as ethylene, propylene, 1-butene, 1-pentene and 1-hexene; vinyl aromatic compounds such as styrene and ⁇ -methylstyrene; Non-conjugated dienes such as 4-hexadiene, 4-methyl-1,4-hexadiene, 5-methyl-1,4-hexadiene, 1,7-octadiene; and the like. Among these, ⁇ -olefin is preferable, and ethylene is more preferable. Other monomers can be used alone or in combination of two or more.
- the ratio of the amount used of the cyclic olefin monomer and the other monomer is a weight ratio (cyclic olefin monomer: other
- the monomer is usually 30:70 to 99: 1, preferably 50:50 to 97: 3, and more preferably 70:30 to 95: 5.
- the polymer ( ⁇ ) may be a block copolymer or a random copolymer. It may be a coalescence.
- the polymer ( ⁇ ) can be synthesized according to a known method using an addition polymerization catalyst.
- addition polymerization catalysts include vanadium catalysts formed from vanadium compounds and organoaluminum compounds, titanium catalysts formed from titanium compounds and organoaluminum compounds, zirconium catalysts formed from zirconium complexes and aluminoxanes, and the like. It is done.
- These addition polymerization catalysts can be used singly or in combination of two or more.
- the amount of addition polymerization catalyst used may be appropriately selected depending on the polymerization conditions and the like, but is usually 0.000001 to 0.1 mol, preferably 0.00001 to 0.01 mol, relative to 1 mol of the monomer. is there.
- the addition polymerization of a cyclocyclic olefin monomer is usually performed in an organic solvent.
- organic solvent include the same solvents as those used for the ring-opening polymerization of the cyclic olefin monomer.
- the polymerization temperature is usually ⁇ 50 to 250 ° C., preferably ⁇ 30 to 200 ° C., more preferably ⁇ 20 to 150 ° C.
- the polymerization time is appropriately selected depending on the polymerization conditions, but is usually 30 minutes to 20 hours, preferably 1 to 10 hours.
- a hydride of the polymer ( ⁇ ) By subjecting the polymer ( ⁇ ) obtained by the above method to a hydrogenation reaction, a hydride of the polymer ( ⁇ ) can be obtained.
- the hydrogenation reaction of the polymer ( ⁇ ) can be carried out by the same method as that shown above as the method for hydrogenating the polymer ( ⁇ ).
- the styrenic thermoplastic elastomer used in the present invention is a block copolymer having a block (A) composed of repeating units derived from styrene monomers and a block (B) composed of repeating units derived from other monomers.
- a block (A) composed of repeating units derived from styrene monomers
- a block (B) composed of repeating units derived from other monomers.
- polymer ( ⁇ ) also referred to as polymer ( ⁇ )
- the block (A) functions as a hard segment
- the block (B) functions as a soft segment
- the block (A) does not mean that all the repeating units are derived from a styrenic monomer.
- a repeating unit derived from a monomer other than a styrenic monomer is blocked (A) because, for example, a part of the monomer used in the previous reaction remains unreacted in the reaction system. ) May be included.
- the content of the repeating unit derived from the styrenic monomer in the block (A) is usually 95 mol% or more, and preferably 99 mol% or more. The same applies to the block (B).
- the styrene monomer used for forming the block (A) of the polymer ( ⁇ ) refers to an aromatic vinyl compound having polymerizability.
- the other monomer used for forming the block (B) of the polymer ( ⁇ ) is not particularly limited as long as it can constitute the soft segment of the thermoplastic elastomer. A mer can be used. Specific examples of the styrene monomer used for forming the block (A) and other monomers used for forming the block (B) are shown in the description of the polymer ( ⁇ ).
- the weight average molecular weight (Mw) of the styrenic thermoplastic elastomer used is 20,000 to 150,000, preferably 20,000 to 100,000, more preferably 30,000 to 80,000.
- Mw weight average molecular weight
- a styrene thermoplastic elastomer having a weight average molecular weight (Mw) of less than 20,000 is used, the resulting resin molded product tends to be inferior in impact resistance and oil resistance.
- a styrene-based thermoplastic elastomer having a weight average molecular weight (Mw) exceeding 150,000 is used, the resulting resin molded product tends to be inferior in transparency.
- the weight average molecular weight (Mw) of the styrene-based thermoplastic elastomer can be controlled by adjusting the amount of the initiator used when the polymer ( ⁇ ) is produced by the method described later.
- the molecular weight distribution (Mw / Mn) of the styrenic thermoplastic elastomer is not particularly limited, but is preferably 1 to 5, more preferably 1 to 4. When the molecular weight distribution of the styrenic thermoplastic elastomer is within the above range, a resin molded body having sufficient mechanical strength can be obtained.
- the weight average molecular weight (Mw) and number average molecular weight (Mn) of the styrenic thermoplastic elastomer are standard polyisoprene conversion values by gel permeation chromatography (GPC) using cyclohexane as an eluent.
- the styrene-based thermoplastic elastomer used in the present invention has a refractive index of the cyclic olefin resin and a difference ( ⁇ nD) between the refractive indexes of more than ⁇ 0.002 and less than 0.002, preferably more than ⁇ 0.001 and less than 0.001. It will be.
- a styrenic thermoplastic elastomer having a refractive index difference ( ⁇ nD) of more than ⁇ 0.002 and less than 0.002 a resin molded article having excellent transparency can be easily obtained.
- “Refractive index difference ( ⁇ nD)” is calculated by the following equation.
- the refractive index of the styrenic thermoplastic elastomer is usually from 1.450 to 1.650, preferably from 1.490 to 1.550.
- the refractive index of the styrene thermoplastic elastomer tends to be affected by the amount of repeating units derived from the styrene monomer and the hydrogenation rate. For example, a styrene-based thermoplastic elastomer having a high refractive index can be easily obtained by increasing the amount of repeating units derived from a styrene-based monomer and increasing the hydrogenation rate.
- styrene-based thermoplastic elastomer examples include a block (A) composed of repeating units derived from a styrene-based monomer, and a block (B1) composed of repeating units derived from isobutylene as a block (B) or a conjugated diene-based single unit. And a block copolymer having a block (B2) composed of a repeating unit derived from a monomer, or a hydride thereof.
- the block (A) consisting of the repeating unit derived from a styrene-type monomer
- the block copolymer which has the block (B1) which consists of a repeating unit derived from isobutylene as a block (B), or its hydride is preferable.
- the method for producing the polymer ( ⁇ ) used as the styrene-based thermoplastic elastomer or its production intermediate (hydrogenation reaction polymer) is not particularly limited.
- a polymer ( ⁇ ) can be obtained by subjecting the monomer corresponding to each block to cationic polymerization sequentially in an inert solvent using a Lewis acid catalyst and an initiator.
- block (A) -block (B) type polymer block (A) -block (B) -block (A) type polymer, block (B) -block (A) -block (B) type polymer, block (A) -block (B) -block (C) type polymer, block (A) -block (C) -block (B) type polymer and the like.
- the block (C) is a block other than the block (A) and the block (B).
- a plurality of blocks (A), blocks (B), blocks (C) Each may be the same or different.
- Styrene monomers used for forming the block (A) of the polymer ( ⁇ ) include styrene; ⁇ -methylstyrene, 2-methylstyrene, 3-methylstyrene, 4-methylstyrene, 2-ethylstyrene, 3 Alkyl substituted styrene monomers such as ethyl styrene, 4-ethyl styrene, 2,4-diisopropyl styrene, 2,4-dimethyl styrene, 4-t-butyl styrene, 5-t-butyl-2-methyl styrene; Halogen-substituted styrene monomers such as 2-chlorostyrene, 3-chlorostyrene, 4-chlorostyrene, 4-bromostyrene, 2,4-dibromostyrene; halogen atoms such as 2-methyl-4,6-dichlorostyren
- styrene monomers can be used alone or in combination of two or more.
- styrene and alkyl-substituted styrene are preferable, and styrene is particularly preferable because a resin molded body excellent in transparency and impact resistance can be easily obtained.
- Monomers used for forming the block (B) of the polymer ( ⁇ ) include isobutylene; 1,3-butadiene, isoprene, 2,3-dimethyl-1,3-butadiene, 1,3-pentadiene, 1, Conjugated diene monomers such as 3-hexadiene and 2-chloro-1,3-butadiene; These monomers can be used alone or in combination of two or more. Among these, isobutylene is preferable because a resin molded body excellent in transparency and impact resistance can be easily obtained.
- the ratio of the block (A) [the total when there are a plurality of blocks (A)] and the block (B) [the total when there are a plurality of blocks (B)] is [block
- the weight ratio of (A): block (B)] is usually 15:85 to 70:30, preferably 20:80 to 60:40.
- block (C) in the polymer ( ⁇ ) a block composed of repeating units derived from monomers such as ethylene; propylene, 1-butene and other ⁇ -olefins; styrenic monomers, isobutylene, conjugated Examples thereof include blocks formed by random polymerization of monomers such as diene monomers, ethylene, and ⁇ -olefin.
- the content of the block (C) is preferably 20% by weight or less, more preferably 15% by weight or less, based on the whole polymer ( ⁇ ).
- Lewis acid catalyst used for producing the polymer ( ⁇ ) examples include titanium tetrachloride, boron trichloride, boron trifluoride, aluminum chloride, tin tetrachloride and the like.
- initiator used for the production of the polymer ( ⁇ ) examples include compounds having an alkoxy group such as bis (2-methoxy-2-propyl) benzene; acyl groups such as bis (2-acetoxy-2-propyl) benzene Compounds; compounds having a halogen atom such as bis (2-chloro-2-propyl) benzene, p-dicumulyl chloride; and the like.
- These Lewis acids and initiators can be used singly or in combination of two or more.
- an amine compound such as triethylamine; an ester compound such as ethyl acetate; an amide compound such as N, N-dimethylacetamide; and the like may be present in the reaction system.
- the presence of these compounds can narrow the molecular weight distribution of the product.
- Examples of the inert solvent used for the production of the polymer ( ⁇ ) include aliphatic hydrocarbon solvents such as n-butane, isobutane, n-pentane and n-hexane; aromatic hydrocarbon solvents such as benzene, toluene and xylene. Alicyclic hydrocarbon solvents such as cyclopentane and cyclohexane; halogenated hydrocarbon solvents such as methyl chloride, dichloromethane, chloroform, ethyl chloride, dichloroethane, butyl chloride and chlorobenzene; These solvents can be used alone or in combination of two or more.
- the polymerization temperature is not particularly limited, but is usually ⁇ 100 to 0 ° C., preferably ⁇ 80 to ⁇ 30 ° C.
- the polymerization time is appropriately selected depending on the polymerization conditions, but is usually 30 minutes to 20 hours, preferably 1 to 10 hours.
- the polymer ( ⁇ ) obtained by the above method may be isolated and purified according to a conventional method and used as a styrenic thermoplastic elastomer, or may be subjected to a hydrogenation reaction to obtain a hydride of the polymer ( ⁇ ). It may be manufactured.
- the hydrogenation reaction of the polymer ( ⁇ ) can be carried out by the same method as described above as the method for hydrogenating the polymer ( ⁇ ).
- the resin composition used in the present invention contains the cyclic olefin resin and the styrenic thermoplastic elastomer.
- the content ratio of the cyclic olefin resin and the styrene thermoplastic elastomer in the resin composition to be used is a weight ratio (cyclic olefin resin: styrene thermoplastic elastomer), preferably 98: 2 to 40:60, more preferably 95. : 5 to 50:50, more preferably 90:10 to 70:30.
- the resin composition of the present invention may contain other components such as additives as long as the effects of the present invention are not impaired.
- other components include an antioxidant, an ultraviolet absorber, a light stabilizer, a near infrared absorber, a plasticizer, an antistatic agent, and an acid scavenger.
- the antioxidant include phenolic antioxidants, phosphorus antioxidants, sulfur antioxidants, and the like.
- phenolic antioxidants include 3,5-di-t-butyl-4-hydroxytoluene, dibutylhydroxytoluene, 2,2'-methylenebis (6-t-butyl-4-methylphenol), 4,4 ' -Butylidenebis (3-t-butyl-3-methylphenol), 4,4'-thiobis (6-t-butyl-3-methylphenol), ⁇ -tocophenol, 2,2,4-trimethyl-6-hydroxy -7-t-butylchroman, tetrakis [methylene-3- (3 ′, 5′-di-t-butyl-4′-hydroxyphenyl) propionate] methane, [pentaerythritol tetrakis [3- (3,5-di -T-butyl-4-hydroxyphenyl) propionate]] and the like.
- phosphorus antioxidants include distearyl pentaerythritol diphosphite, bis (2,4-ditertiarybutylphenyl) pentaerythritol diphosphite, tris (2,4-ditertiarybutylphenyl) phosphite, tetrakis (2 , 4-ditertiary butylphenyl) 4,4′-biphenyl diphosphite, trinonylphenyl phosphite and the like.
- sulfur-based antioxidants examples include distearyl thiodipropionate and dilauryl thiodipropionate.
- UV absorber examples include benzotriazole UV absorbers, bezoate UV absorbers, benzophenone UV absorbers, acrylate UV absorbers, and metal complex UV absorbers.
- light stabilizer examples include hindered amine light stabilizers.
- near infrared absorbers cyanine near infrared absorbers; pyrylium infrared absorbers; squarylium near infrared absorbers; croconium infrared absorbers; azulenium near infrared absorbers; phthalocyanine near infrared absorbers; dithiol metal complexes System near infrared absorbers; naphthoquinone near infrared absorbers; anthraquinone near infrared absorbers; indophenol near infrared absorbers;
- the plasticizer include a phosphoric acid triester plasticizer, a fatty acid monobasic acid ester plasticizer, a dihydric alcohol ester plasticizer, and an oxyacid ester plasticizer.
- the antistatic agent include fatty acid esters of polyhydric alcohols.
- the acid supplement include magnesium oxide and zinc stearate.
- the content of these components can be appropriately determined according to the purpose.
- the content of each of these components is usually in the range of 0.001 to 5 parts by weight, preferably 0.01 to 1 part by weight, based on 100 parts by weight of the total of the cyclic olefin resin and the styrenic thermoplastic elastomer. .
- the resin composition of the present invention can be obtained by mixing each component according to a conventional method.
- the mixing method include a method of mixing each component in an appropriate solvent and a method of kneading in a molten state.
- Kneading can be performed using a melt kneader such as a single screw extruder, a twin screw extruder, a Banbury mixer, a kneader, or a feeder ruder.
- the kneading temperature is preferably in the range of 200 to 400 ° C, more preferably 240 to 350 ° C.
- the components may be added together and kneaded, or may be kneaded while adding in several times. After kneading, it can be pelletized by extruding into a rod shape and cutting into an appropriate length with a strand cutter according to a conventional method.
- the resin composition of the present invention has a residue of 0.10% by weight or less, preferably 0.08% by weight or less when analyzed based on the ignition residue test method prescribed in the Japanese Pharmacopoeia. . There is no particular lower limit, and the lower the better, the better, but usually 0.05% by weight or more. By using a resin composition having a balance of 0.10% by weight or less, a resin molded article suitable for medical use can be obtained.
- the residue in the ignition residue test method is mainly a metal derived from a polymerization catalyst or a hydrogenation catalyst used when synthesizing a cyclic olefin resin or a styrene thermoplastic elastomer. Therefore, a resin composition with less residue is obtained by selecting a catalyst having higher activity as these catalysts, or sufficiently removing catalyst residues from the product after the polymerization reaction or hydrogenation reaction. be able to. Further, by using a highly active catalyst, the amount of catalyst used can be reduced as a result.
- the light transmittance of light having a wavelength of 450 nm is 55. % Or more, preferably 60% or more, more preferably 70% or more. There is no particular upper limit value, and the higher the value, the better, but it is usually 90% or less.
- Cyclic olefin resins are generally excellent in transparency and have high light transmittance.
- a styrene thermoplastic elastomer when blended, the transparency of the resulting resin molded product tends to decrease. Therefore, in the present invention, it is necessary to use an appropriate combination of a cyclic olefin resin and a styrene thermoplastic elastomer. is there.
- the light transmittance tends to be increased by reducing the difference ( ⁇ nD) between the refractive index of the cyclic olefin resin and the refractive index of the styrene-based thermoplastic elastomer.
- the said light transmittance to increase, so that the molecular weight of a styrene-type thermoplastic elastomer is small and content in a resin composition is small. Therefore, for example, after determining the cyclic olefin resin to be used, a resin composition in which the repeating unit, weight average molecular weight, and blending amount in the styrene thermoplastic elastomer are appropriately adjusted while considering other characteristics such as impact resistance. By using it, the target resin molding can be obtained.
- the resin composition of the present invention is formed into a shape of thickness 4.0 mm ⁇ length 80.0 mm ⁇ width 10.0 mm, and a notched Charpy impact test specified in JIS K7111-1 is used at 23 ° C.
- the Charpy impact strength is 5 to 40 kJ / m 2 , preferably 5 to 30 kJ / m 2 .
- a resin composition having a Charpy impact strength of less than 5 kJ / m 2 is used, the resulting resin molded article tends to be inferior in impact resistance and oil resistance.
- a resin composition having a Charpy impact strength of more than 40 kJ / m 2 is used, the resulting resin molded product has a low light transmittance and tends to be unsuitable for medical use.
- the cyclocyclic olefin resin generally tends to be inferior in impact resistance.
- a resin molded article having excellent impact resistance can be obtained without adversely affecting the above transparency by using an appropriate combination of styrene thermoplastic elastomers having a specific weight average molecular weight.
- a resin molded body used in the medical field or the like needs to have a small residue in the ignition residue test method and have an excellent balance between transparency and impact resistance.
- the ignition residue test method which is an appropriate combination of a cyclic olefin resin and a styrene-based thermoplastic elastomer. It is important to use a resin composition.
- a hydride of norbornene-based ring-opening polymer is used as a cyclic olefin resin, a block (A) composed of a repeating unit derived from a styrene-based monomer as a styrene-based thermoplastic elastomer, and isobutylene
- blended both by preferable weight ratio using the hydride thereof is mentioned.
- the resin molded body of the present invention is obtained by molding the resin composition.
- the molding method used when producing the resin molded body of the present invention is not particularly limited, and examples thereof include an injection molding method, a press molding method, an extrusion molding method, and a blow molding method.
- the melting temperature at the time of molding varies depending on the resin composition used, but is usually 200 to 400 ° C., preferably 210 to 350 ° C.
- the mold temperature in the case of using a mold is usually 20 ° C. to (Tg + 15) ° C., preferably (Tg ⁇ 30) ° C. to (Tg + 10) ° C., more preferably when the glass transition temperature of the resin composition is Tg. Is a temperature from (Tg ⁇ 20) ° C. to (Tg + 5) ° C.
- a blow molding method is preferably used.
- Blow molding can be performed according to a conventional method. For example, first, a preform is obtained by molding into a sheet shape, a pipe shape, or a tube shape using an injection molding method or an extrusion molding method, and then the preform is subjected to blow molding to obtain a target container or the like. Can be manufactured.
- the blow ratio in blow molding is not particularly limited, but is usually 1.3 to 50 times, preferably 2 to 30 times, more preferably 3 to 10 times.
- the blow magnification is a value obtained by dividing the thickness of the parison wall by the thickness of the container wall after blow. For example, when the average thickness of the parison wall is 5 mm and the average thickness of the container wall after blowing is 1 mm, the blow magnification is 5 times.
- the styrene thermoplastic elastomer to be blended is used.
- a resin composition obtained by blending a styrene-based thermoplastic elastomer having a weight average molecular weight that is too large is likely to be inferior in moldability, such as a precision part or a container having a complicated shape.
- the resin composition used in the present invention provides a resin molded article excellent in impact resistance without using a styrene-based thermoplastic elastomer having a weight average molecular weight that is too large. Therefore, even when the blow molding method is employed as the molding method, the target resin molded body can be stably produced.
- the resin composition used for the production of the resin molded body of the present invention contains a specific cyclic olefin resin and a styrene-based thermoplastic elastomer, and is based on the ignition residue test method prescribed in the Japanese Pharmacopoeia.
- the sheet-like molded product shows a specific light transmittance and Charpy impact strength.
- the resin molded product of the present invention obtained using such a resin composition is excellent in oil resistance and molding processability as shown in Examples, it is preferably used in the medical field and the like.
- the resin molded body of the present invention include containers such as pharmaceutical containers, cosmetic containers, and food containers; medical instruments such as disposable syringes, infusion bags, scalpels, forceps, and liquid feeding tubes; petri dishes, culture containers, disposable pipettes, and the like Lab equipment; and the like.
- the measuring methods for various physical properties are as follows.
- Weight average molecular weight (Mw) and number average molecular weight (Mn) The weight average molecular weight (Mw) and number average molecular weight (Mn) of the cyclic olefin resins and styrene-based thermoplastic elastomers obtained in Production Examples 1 to 5 are gel permeation chromatography (GPC) using cyclohexane as an eluent. Measured as a standard polyisoprene conversion value.
- GPC gel permeation chromatography
- the glass transition temperature (Tg) was measured by the following method using a differential scanning calorimeter (DSC6220S11, manufactured by Nanotechnology) based on JIS K7121.
- the test piece was heated to a temperature higher by 30 ° C. or more than the glass transition temperature, cooled to room temperature at a cooling rate of ⁇ 10 ° C./min, and then heated at a temperature rising rate of 10 ° C./min. In this temperature rising process, the glass transition temperature (Tg) was measured.
- the refractive index was measured using a Karnew refractometer (KPR-200, manufactured by Karnew Optical Co., Ltd.). A resin molded body of 40 mm ⁇ 40 mm ⁇ 3.0 mm was used as a test piece, and the refractive index in light having a wavelength of 587.6 nm was measured at 25 ° C. Next, the difference in refractive index ( ⁇ nD) in the resin composition was calculated based on the above formula.
- Residue test on ignition Residue test was performed according to the Japanese Pharmacopoeia plastic drug container test using pellets which are intermediate products in Examples and Comparative Examples as measurement samples.
- the obtained toluene solution was washed twice with water, and then the toluene solution was added to a large amount of methanol to precipitate a polymer [styrene-based thermoplastic elastomer (1)].
- the weight average molecular weight (Mw) of the styrene-based thermoplastic elastomer (1) was 70,000, the ratio of the styrene block to the isobutylene block was 33:67 by weight, and the refractive index was 1.5350.
- Styrenic thermoplastic elastomer (2) was obtained in the same manner as in Production Example 2, except that the amount of p-dicumulyl chloride added in Production Example 2 was changed to 1.63 g (7.0 mmol).
- the weight average molecular weight (Mw) of the styrene-based thermoplastic elastomer (2) was 40,000, the ratio of the styrene block to the isobutylene block was 33:67 by weight, and the refractive index was 1.5343.
- a styrenic thermoplastic elastomer (3) was obtained in the same manner as in Production Example 2, except that the amount of p-dicumulyl chloride added was changed to 4.33 g (19 mmol) in Production Example 2.
- the weight average molecular weight (Mw) of the styrene-based thermoplastic elastomer (3) was 15,000, the ratio of the styrene block to the isobutylene block was 33:67 by weight, and the refractive index was 1.5341.
- a styrenic thermoplastic elastomer (4) was obtained in the same manner as in Production Example 2, except that the amount of p-dicumulyl chloride added in Production Example 2 was changed to 0.325 g (1.4 mmol).
- the weight average molecular weight (Mw) of the styrene-based thermoplastic elastomer (4) was 200,000, the ratio of the styrene block to the isobutylene block was 33:67 by weight, and the refractive index was 1.5340.
- Example 1 90 parts of the cyclic olefin resin (1) obtained in Production Example 1, 10 parts of the styrenic thermoplastic elastomer (1) obtained in Production Example 2, an antioxidant [pentaerythritol tetrakis [3- (3,5-di-t -Butyl-4-hydroxyphenyl) propionate]] and 0.3 part of an acid scavenger [magnesium oxide] were mixed in a blender and then vacuum dried at 70 ° C. and 0.1 hPa for 6 hours. Next, using a biaxial kneader in which the hopper was replaced with nitrogen, the hopper was kneaded at 270 ° C. and then extruded to be pelletized.
- injection molding was performed at a resin temperature of 265 ° C. and a mold temperature of 60 ° C. to prepare a preform having a total length of 145.4 mm, a maximum outer shape of 29.7 mm, and a wall thickness of 4.7 mm.
- This preform was subjected to a longitudinal 1. in a blow molding machine (manufactured by Frontier, model “EFB-1000ET”) under the conditions of a preform heating temperature of 178 ° C., a blow time of 2.10 seconds, and a cycle time of 5.26 seconds.
- the product was stretched 55 times and 2.00 times in width to produce a blow molded product.
- a drop impact test and an oil resistance test were conducted.
- the pellets were injection molded at a resin temperature of 265 ° C. and a mold temperature of 120 ° C. to prepare a light transmittance measurement test piece and a Charpy impact test test piece, and each test was performed.
- Example 2 In Example 1, the amount of the cyclic olefin resin (1) was changed to 80 parts, and the amount of the styrene-based thermoplastic elastomer (1) was changed to 20 parts. A molded body was obtained and subjected to each test.
- Example 3 In Example 1, pellets and resin were obtained in the same manner as in Example 1 except that the amount of cyclic olefin resin (1) used was changed to 70 parts and the amount of styrene thermoplastic elastomer (1) used was changed to 30 parts. A molded body was obtained and subjected to each test.
- Example 4 In Example 2, pellets and resin moldings were obtained in the same manner as in Example 2 except that the styrene-based thermoplastic elastomer (1) was changed to 20 parts of the styrene-based thermoplastic elastomer (2). Went.
- Example 1 In Example 1, the amount of the cyclic olefin resin (1) was changed to 99 parts, and the amount of the styrene-based thermoplastic elastomer (1) was changed to 1 part. A molded body was obtained and subjected to each test.
- Example 2 In Example 1, pellets and resin were obtained in the same manner as in Example 1 except that the amount of cyclic olefin resin (1) used was changed to 60 parts and the amount of styrene-based thermoplastic elastomer (1) used was changed to 40 parts. A molded body was obtained and subjected to each test.
- Example 3 In Example 2, except that the styrene thermoplastic elastomer (1) was changed to 20 parts of the styrene thermoplastic elastomer (3), pellets and resin molded bodies were obtained in the same manner as in Example 2, and each test Went.
- Example 4 pellets were obtained in the same manner as in Example 2 except that the styrene thermoplastic elastomer (1) was changed to 20 parts of the styrene thermoplastic elastomer (4). However, since the melt viscosity is too large, the intended resin molded body could not be obtained using the obtained pellets.
- Examples 1 to 4 a bottle-shaped resin molded body is obtained by blow molding. Moreover, the resin molding obtained using the resin composition used at this time is hard to be damaged at the time of dropping, is excellent in oil resistance, and is particularly preferably used in medical applications. On the other hand, the resin molded bodies of Comparative Examples 1 and 3 are easily damaged when dropped, and are inferior in oil resistance. The resin molded body of Comparative Example 2 is inferior in transparency and is not suitable for medical use. Moreover, in the comparative example 4, since the moldability of a resin composition is inferior, it cannot blow-mold in the target shape.
Abstract
Description
しかしながら、一般に、環状オレフィン樹脂は剛性が高いため、従来の環状オレフィン樹脂製品は、耐衝撃性や、スチーム滅菌処理に対する耐久性に劣り易いという問題があった。
しかしながら、これらの文献に記載の樹脂組成物を用いて得られる医薬品容器や医療用器具は、目的の要求性能を十分に満たすものとはいえなかった。
〔1〕環状オレフィン樹脂、及び、スチレン系熱可塑性エラストマーを含有する樹脂組成物を成形して得られた樹脂成形体であって、
前記スチレン系熱可塑性エラストマーは、重量平均分子量(Mw)が20,000~150,000で、かつ、前記環状オレフィン樹脂の屈折率との屈折率の差(ΔnD)が-0.002超+0.002未満のものであり、
前記樹脂組成物を、日本薬局方に規定の強熱残分試験法に基づいて分析したときに、残分が0.10重量%以下、
前記樹脂組成物を、厚さが3.0mmのシート状に成形して、これを用いて光線透過率を測定したときに、波長が450nmの光の光線透過率(光路長3mm)が55%以上、かつ、
前記樹脂組成物を、厚さ4.0mm×長さ80.0mm×幅10.0mmの形状に成形して、これを用いてJIS K7111-1に規定されるノッチ付きシャルピー衝撃試験を23℃で行ったときに、シャルピー衝撃強さが5~40kJ/m2であることを特徴とする樹脂成形体。
〔2〕前記スチレン系熱可塑性エラストマーが、スチレン系単量体由来の繰り返し単位からなるブロック(A)と、イソブチレン由来の繰り返し単位からなるブロック(B1)又は共役ジエン系単量体由来の繰り返し単位からなるブロック(B2)とを有するブロック共重合体、又はその水素化物である、〔1〕に記載の樹脂成形体。
〔3〕前記樹脂組成物中における、前記環状オレフィン樹脂とスチレン系熱可塑性エラストマーの含有量比が、重量比(環状オレフィン樹脂:スチレン系熱可塑性エラストマー)で、98:2~40:60である、〔1〕又は〔2〕に記載の樹脂成形体。
(i)前記スチレン系熱可塑性エラストマーが、重量平均分子量(Mw)が20,000~150,000で、かつ、前記環状オレフィン樹脂の屈折率との屈折率の差(ΔnD)が-0.002超+0.002未満のものである。
(ii)前記樹脂組成物を、日本薬局方に規定の強熱残分試験法に基づいて分析したときに、残分が0.10重量%以下である。
(iii)前記樹脂組成物を、厚さが3.0mmのシート状に成形して、これを用いて光線透過率を測定したときに、波長が450nmの光の光線透過率(光路長3mm)が55%以上である。
(iv)前記樹脂組成物を、厚さ4.0mm×長さ80.0mm×幅10.0mmの形状に成形して、これを用いてJIS K7111-1に規定されるノッチ付きシャルピー衝撃試験を23℃で行ったときに、シャルピー衝撃強さが5~40kJ/m2である。
本発明に用いる環状オレフィン樹脂は、分子内に、脂環式構造を有する重合体であって、環状オレフィンを単量体として用いて重合反応を行って得られた重合体又はその水素化物である。
環状オレフィン樹脂の脂環式構造としては、シクロアルカン構造やシクロアルケン構造が挙げられる。これらの中でも、耐光性、耐久性等に優れる樹脂成形体が得られ易いことから、シクロアルカン構造が好ましい。脂環式構造を構成する炭素原子の数は、特に制限はないが、通常4~30個、好ましくは5~20個、より好ましくは5~15個である。
環状オレフィン樹脂の分子量分布が上記範囲内にあることで、十分な機械的強度を有する樹脂成形体を得ることができる。
環状オレフィン樹脂の重量平均分子量(Mw)及び数平均分子量(Mn)は、シクロヘキサンを溶離液とするゲル・パーミエーション・クロマトグラフィー(GPC)による標準ポリイソプレン換算値である。
本発明において、屈折率とは、25℃で、波長が587.6nmの光を照射して測定したものをいう。
環状オレフィン樹脂の屈折率が上記範囲内にあることで、環状オレフィン樹脂の屈折率と、スチレン系熱可塑性エラストマーの屈折率の差(ΔnD)をより容易に小さくすることができる。
各種特性についてバランスよく優れており、目的の樹脂成形体が得られ易いことから、環状オレフィン樹脂としては、重合体(α)の水素化物が好ましい。
重合体(α)及びその水素化物の製造に用いる、環状オレフィン単量体は、炭素原子で形成される環構造を有し、該環中に炭素-炭素二重結合を有する化合物である。具体的には、ノルボルネン系単量体等が挙げられる。また、重合体(α)が共重合体である場合には、環状オレフィン単量体として、単環の環状オレフィンを用いることもできる。
ノルボルネン系単量体としては、ビシクロ[2.2.1]ヘプト-2-エン(慣用名:ノルボルネン)、5-エチリデン-ビシクロ[2.2.1]ヘプト-2-エン(慣用名:エチリデンノルボルネン)及びその誘導体(環に置換基を有するもの)等の2環式単量体;トリシクロ[4.3.0.12,5]デカ-3,7-ジエン(慣用名:ジシクロペンタジエン)及びその誘導体等の3環式単量体;
7,8-ベンゾトリシクロ[4.3.0.12,5]デカ-3-エン(慣用名:メタノテトラヒドロフルオレン、テトラシクロ[7.4.0.02,7.110,13]トリデカ-2,4,6,11-テトラエンともいう)及びその誘導体、テトラシクロ[4.4.0.12,5.17,10]ドデカ-3-エン(慣用名:テトラシクロドデセン)、8-エチリデンテトラシクロ[4.4.0.12,5.17,10]-3-ドデセン及びその誘導体等の4環式単量体;等が挙げられる。
環状オレフィン単量体を2種以上用いる場合、重合体(α)は、ブロック共重合体であってもよいし、ランダム共重合体であってもよい。
これらの中でも、環状オレフィン単量体としては、トリシクロ[4.3.0.12,5]デカ-3,7-ジエン、8-メチル-テトラシクロ[4.4.0.12,5.17,10]ドデカ-3-エン、テトラシクロ[7.4.0.02,7.110,13]トリデカ-2,4,6,11-テトラエンが好ましい。
メタセシス重合触媒としては、特に限定はなく公知のものが用いられる。メタセシス重合触媒としては、ルテニウム、ロジウム、パラジウム、オスミウム、イリジウム及び白金などから選ばれる金属のハロゲン化物、硝酸塩又はアセチルアセトン化合物と、還元剤とからなる触媒系;チタン、バナジウム、ジルコニウム、タングステン及びモリブデンから選ばれる金属のハロゲン化物又はアセチルアセトン化合物と、助触媒の有機アルミニウム化合物とからなる触媒系;シュロック型又はグラブス型のリビング開環メタセシス重合触媒(特開平7-179575号、J.Am.Chem.Soc.,1986年,108,p.733、J.Am.Chem.Soc.,1993年,115,p.9858、及びJ.Am.Chem.Soc.,1996年,118,p.100);等が挙げられる。
これらのメタセシス重合触媒は、1種単独で、あるいは2種以上を組み合わせて用いることができる。
直鎖α-オレフィンの添加量は、環状オレフィン単量体1モルに対して、通常0.001~0.030モル、好ましくは0.003~0.020モル、より好ましくは0.005~0.015モルである。
重合体(α)の水素化反応は、常法に従って、水素化触媒の存在下に、重合体(α)を水素と接触させることにより行うことができる。
均一系触媒は、水素化反応液中で分散しやすいため、触媒の添加量を抑えることができる。また、高温高圧にしなくても十分な活性を有するため、重合体(α)やその水素化物の分解やゲル化が起こりにくい。このため、費用面や生成物の品質の観点から選択される。
一方、不均一系触媒は、高温高圧下において特に優れた活性を示すため、短時間で重合体(α)を水素化することができる。また、水素化反応後に、触媒残渣を効率よく除去することができる。
特に、環状オレフィン樹脂に不純物として含まれる触媒残渣等を十分に除去することができ、残分(日本薬局方に規定の強熱残分試験法による残分)が低い樹脂成形体が得られ易いことから、本発明においては、不均一系触媒を用いて重合体(α)の水素化反応を行うことが好ましい。
これらの有機溶媒は、1種単独で、あるいは2種以上を組み合わせて用いることができる。また、通常は、開環重合反応に用いた溶媒は、水素化反応の溶媒としても適するため、開環重合反応液に水素化触媒を添加した後、それを水素化反応に供することができる。
重合体(β)及びその水素化物の合成に用いる環状オレフィン単量体としては、重合体(α)の合成に用いる環状オレフィン単量体として示したものと同様のものが挙げられる。
重合体(β)の合成においては、単量体として、環状オレフィン単量体とともに、このものと共重合可能なその他の単量体を用いることもできる。
その他の単量体としては、エチレン、プロピレン、1-ブテン、1-ペンテン、1-ヘキセン等の炭素数2~20のα-オレフィン;スチレン、α-メチルスチレン等の芳香環ビニル化合物;1,4-ヘキサジエン、4-メチル-1,4-ヘキサジエン、5-メチル-1,4-ヘキサジエン、1,7-オクタジエン等の非共役ジエン;等が挙げられる。これらの中でも、α-オレフィンが好ましく、エチレンがより好ましい。
その他の単量体は、1種単独で、あるいは2種以上を組み合わせて用いることができる。
付加重合触媒としては、バナジウム化合物及び有機アルミニウム化合物から形成されるバナジウム系触媒、チタン化合物及び有機アルミニウム化合物から形成されるチタン系触媒、ジルコニウム錯体及びアルミノオキサンから形成されるジルコニウム系触媒等が挙げられる。
これらの付加重合触媒は、1種単独で、あるいは2種以上を組み合わせて用いることができる。付加重合触媒の使用量は、重合条件等により適宜選択すればよいが、単量体1モルに対して、通常0.000001~0.1モル、好ましくは、0.00001~0.01モルである。
重合体(β)の水素化反応は、重合体(α)を水素化する方法として先に示したものと同様の方法により行うことができる。
本発明に用いるスチレン系熱可塑性エラストマーは、スチレン系単量体由来の繰り返し単位からなるブロック(A)と、その他の単量体由来の繰り返し単位からなるブロック(B)とを有するブロック共重合体(以下、重合体(γ)ということがある。)であって、前記ブロック(A)がハードセグメントとして機能し、前記ブロック(B)がソフトセグメントとして機能する熱可塑性エラストマー、又は、前記重合体(γ)の水素化物であって、前記ブロック(A)が水素化されてなる部分がハードセグメントとして機能し、前記ブロック(B)が水素化されてなる部分がソフトセグメントとして機能する熱可塑性エラストマーである。
また、これらのことは、ブロック(B)についても同様である。
重合体(γ)のブロック(B)の形成に用いるその他の単量体は、熱可塑性エラストマーのソフトセグメントを構成し得るものであれば、特に限定されず、熱可塑性エラストマー合成用として公知の単量体を利用することができる。
ブロック(A)の形成に用いるスチレン系単量体や、ブロック(B)の形成に用いるその他の単量体の具体例は、重合体(γ)の説明の中で示す。
スチレン系熱可塑性エラストマーの重量平均分子量(Mw)は、後述する方法により重合体(γ)を製造する場合、用いる開始剤の量を調節することにより制御することができる。
スチレン系熱可塑性エラストマーの分子量分布が上記範囲内にあることで、十分な機械的強度を有する樹脂成形体を得ることができる。
スチレン系熱可塑性エラストマーの重量平均分子量(Mw)及び数平均分子量(Mn)は、シクロヘキサンを溶離液とするゲル・パーミエーション・クロマトグラフィー(GPC)による標準ポリイソプレン換算値である。
屈折率の差(ΔnD)が-0.002超+0.002未満のスチレン系熱可塑性エラストマーを用いることで、透明性に優れる樹脂成形体が得られ易くなる。
「屈折率の差(ΔnD)」は、下記式により算出される。
スチレン系熱可塑性エラストマーの屈折率は、スチレン系単量体由来の繰り返し単位の量や、水素化率の影響を受ける傾向がある。例えば、スチレン系単量体由来の繰り返し単位の量を多くし、また、水素化率を高くすることにより、屈折率が高いスチレン系熱可塑性エラストマーが得られ易くなる。
なお、前記ブロック(C)は、前記ブロック(A)及びブロック(B)以外のブロックである。また、重合体(γ)が、ブロック(A)、(B)、(C)をそれぞれ2以上有するとき、複数の、ブロック(A)同士、ブロック(B)同士、ブロック(C)同士は、それぞれ同一であっても、相異なっていてもよい。
これらの中でも、透明性及び耐衝撃性に優れる樹脂成形体が得られ易いことから、スチレン、アルキル置換スチレンが好ましく、スチレンが特に好ましい。
これらの中でも、透明性及び耐衝撃性に優れる樹脂成形体が得られ易いことから、イソブチレンが好ましい。
重合体(γ)の製造に用いる開始剤としては、ビス(2-メトキシ-2-プロピル)ベンゼン等のアルコキシ基を有する化合物;ビス(2-アセトキシ-2-プロピル)ベンゼン等のアシル基を有する化合物;ビス(2-クロロ-2-プロピル)ベンゼン、p-ジクミルクロライド等のハロゲン原子を有する化合物;が挙げられる。
これらのルイス酸や開始剤は、1種単独で、あるいは2種以上を組み合わせて用いることができる。
これらの溶媒は、1種類を単独で、あるいは2種以上を組み合わせて用いることができる。
重合体(γ)の水素化反応は、重合体(α)を水素化する方法として先に示したものと同様の方法により行うことができる。
本発明に用いる樹脂組成物は、前記環状オレフィン樹脂と、前記スチレン系熱可塑性エラストマーとを含有する。
用いる樹脂組成物中の環状オレフィン樹脂とスチレン系熱可塑性エラストマーの含有量比は、重量比(環状オレフィン樹脂:スチレン系熱可塑性エラストマー)で、好ましくは98:2~40:60、より好ましくは95:5~50:50、さらに好ましくは90:10~70:30である。
スチレン系熱可塑性エラストマーが十分に含まれる樹脂組成物を用いることで、耐衝撃性及び耐油性に優れる樹脂成形体が得られ易くなる。一方、環状オレフィン樹脂が十分に含まれる樹脂組成物を用いることで、透明性に優れ、医療用途に適する樹脂成形体が得られ易くなる。
その他の成分としては、酸化防止剤、紫外線吸収剤、光安定剤、近赤外線吸収剤、可塑剤、帯電防止剤、酸補足剤等が挙げられる。
酸化防止剤としては、フェノール系酸化防止剤、リン系酸化防止剤、イオウ系酸化防止剤等が挙げられる。
光安定剤としては、ヒンダードアミン系光安定剤が挙げられる。
可塑剤としては、リン酸トリエステル系可塑剤、脂肪酸一塩基酸エステル系可塑剤、二価アルコールエステル系可塑剤、オキシ酸エステル系可塑剤等が挙げられる。
帯電防止剤としては、多価アルコールの脂肪酸エステル等が挙げられる。
酸補足剤としては、酸化マグネシウム、ステアリン酸亜鉛等が挙げられる。
混錬後は、常法に従って、棒状に押出し、ストランドカッターで適当な長さに切ることで、ペレット化することができる。
この残分が0.10重量%以下である樹脂組成物を用いることで、医療用途に適した樹脂成形体を得ることができる。
この光線透過率が55%以上の樹脂組成物を用いることで、医療用途に適した樹脂成形体を得ることができる。
本発明においては、前記環状オレフィン樹脂の屈折率と、前記スチレン系熱可塑性エラストマーの屈折率の差(ΔnD)を小さくすることで、前記光線透過率が高まる傾向がある。
また、スチレン系熱可塑性エラストマーの分子量が小さく、樹脂組成物中の含有量が少ないほど、前記光線透過率が高まる傾向がある。
したがって、例えば、用いる環状オレフィン樹脂を決定した後、耐衝撃性等の他の特性を考慮しながら、スチレン系熱可塑性エラストマー中の繰り返し単位、重量平均分子量、配合量を適宜調節した樹脂組成物を用いることで、目的の樹脂成形体を得ることができる。
このシャルピー衝撃強さが5kJ/m2未満の樹脂組成物を用いると、得られる樹脂成形体の耐衝撃性や耐油性が劣り易くなる。一方、このシャルピー衝撃強さが40kJ/m2を超える樹脂組成物を用いると、得られる樹脂成形体は、光線透過率が低く、医療用途には適さないものになり易くなる。
本発明の樹脂成形体は、前記樹脂組成物を成形して得られたものである。
本発明の樹脂成形体を製造する際に用いる成形方法は、特に限定されず、射出成形法、プレス成形法、押出し成形法、ブロー成形法等が挙げられる。
成形時の溶融温度は、用いる樹脂組成物によっても異なるが、通常200~400℃、好ましくは210~350℃である。金型を使用する場合の金型温度は、樹脂組成物のガラス転移温度をTgとすると、通常、20℃から(Tg+15)℃、好ましくは(Tg-30)℃から(Tg+10)℃、より好ましくは(Tg-20)℃から(Tg+5)℃の温度である。
ブロー成形は、常法に従って行うことができる。例えば、まず、射出成型法、押出し成形法を利用して、シート状、パイプ状、チューブ状に成形してプリフォームを得た後、このプリフォームをブロー成形に供することで目的の容器等を製造することができる。
ブロー倍率とは、パリソン壁の厚さを、ブロー後の容器壁の厚さで割った値のことである。例えば、パリソン壁の厚みの平均が5mmでブロー後の容器壁の厚さの平均が1mmであるときは、ブロー倍率は5倍となる。
しかしながら、後述する比較例で示されるように、重量平均分子量が大き過ぎるスチレン系熱可塑性エラストマーを配合して得られる樹脂組成物は、成形性に劣り易く、精密部品や、複雑な形状の容器等を製造する際の製造原料としては適していなかった。
この点、本発明に用いる樹脂組成物は、重量平均分子量が大き過ぎるスチレン系熱可塑性エラストマーを用いることなく、耐衝撃性に優れる樹脂成形体を与えるものである。したがって、成形方法としてブロー成形法を採用する場合であっても、安定的に目的の樹脂成形体を製造することができる。
本発明の樹脂成形体としては、医薬品容器、化粧品容器、食品用容器等の容器類;ディスポーザブルシリンジ、輸液バッグ、メス、鉗子、送液管等の医療用器具;シャーレ、培養容器、ディスポーザブルピペット等の実験器具;等が挙げられる。
(1)重量平均分子量(Mw)及び数平均分子量(Mn)
製造例1~5で得られた環状オレフィン樹脂、スチレン系熱可塑性エラストマーの重量平均分子量(Mw)と数平均分子量(Mn)は、シクロヘキサンを溶離液とするゲル・パーミエーション・クロマトグラフィー(GPC)による標準ポリイソプレン換算値として測定した。
(2)水素添加率
製造例1において、水素化反応における水素添加率は、1H-NMRを用いて測定した。
(3)ガラス転移温度(Tg)
製造例1において、ガラス転移温度(Tg)は、JIS K 7121に基づき、示差走査熱量分析計(ナノテクロノジー社製、DSC6220S11)を用いて以下の方法により測定した。
試験片を、ガラス転移温度より30℃以上高い温度になるまで加熱した後、冷却速度-10℃/分で室温まで冷却し、次いで、昇温速度10℃/分で昇温した。この昇温過程において、ガラス転移温度(Tg)を測定した。
製造例1~5において、屈折率は、カルニュー屈折計(カルニュー光学工業社製、KPR-200)を用いて測定した。試験片として、40mm×40mm×3.0mmの樹脂成形体を使用し、25℃で、波長587.6nmの光における屈折率を測定した。
次いで、前記式に基づき、樹脂組成物における屈折率の差(ΔnD)を算出した。
実施例及び比較例における中間製造物であるペレットを測定試料として用いて、日本薬局方 プラスチック製医薬品容器試験に準拠し、強熱残分試験を行った。
実施例及び比較例において射出成形法により得られた、厚さ3.0mmの試験片について、紫外可視赤外分光光度計(日本分光社製、V-570)を用いて、波長が450nmの光の光線透過率(光路長3mm)を測定した。
実施例及び比較例において、射出成形法により得られた厚さ4.0mm×長さ80.0mm×幅10.0mmの試験片(ノッチ付き)について、JIS K7111-1に準拠し、シャルピー衝撃試験を行った。
実施例及び比較例において、ボトル状にブロー成形して得られた試験体に純水を充填後、キャップを締めて密封し、温度23℃、湿度50%下に1時間静置した。その後、前記試験体の底面を下向きにし、高さ1.8mから鉛直方向に繰り返し落下させ、亀裂が入った時点での落下回数を調べた。第1表、第2表中、「10」の表記は、落下10回後も亀裂がみられなかったことを表し、10未満の数値の表記は、亀裂が入った時点の落下回数を表す。
実施例及び比較例において、ボトル状にブロー成形して得られた試験体の外表面に、ニベアクリーム(登録商標、ニベア花王社製)を塗布し、40℃で24時間静置した後、亀裂の発生の有無を調べ、以下の基準で耐油性を評価した。
「○」・・・亀裂なし
「×」・・・亀裂あり
医療用樹脂成形体を製造する際に必要な特性である、樹脂組成物の成形加工性(ブロー成形できるか否か)、強熱残分量(前記強熱残分が0.10重量%以下であるか否か)、透明性(前記光線透過率が55%以上であるか否か)の観点から、樹脂成形体の医療用途適合性を評価した。これらの3つの特性全てに優れるものを○、少なくも1つの項目で劣っているものを×とした。
窒素雰囲気下、室温で、脱水シクロヘキサン500部、1-ヘキセン0.82部、ジブチルエーテル0.15部、トリイソブチルアルミニウム0.30部を反応器に入れ、全容を混合した後、さらに、45℃で、トリシクロ[4.3.0.12,5]デカ-3,7-ジエン(慣用名:ジシクロペンタジエン、以下、「DCP」と略記する。)76部、8-メチル-テトラシクロ[4.4.0.12,5.17,10]ドデカ-3-エン(以下「TCD」と略す)70部、テトラシクロ[7.4.0.02,7.110,13]トリデカ-2,4,6,11-テトラエン(以下「MTF」と略す)54部、六塩化タングステン(0.7%トルエン溶液)80部を、それぞれ2時間かけて連続的に滴下し、開環重合反応を行った。
次いで、反応液にブチルグリシジルエーテル1.06部とイソプロピルアルコール0.52部を加えて、開環重合反応を停止させた。反応液をガスクロマトグラフィーで分析したところ、各モノマーの重合転化率は、99.5%であった。
次いで、ろ過により反応液から水素化触媒を除去した後、円筒型濃縮乾燥器(日立製作所社製)を用いて、温度270℃、圧力1kPa以下の条件で、ろ液から、シクロヘキサン及びその他の揮発成分を除去することにより、開環重合体水素化物〔環状オレフィン樹脂(1)〕を得た。
次いで、溶融押出し機を用いて、環状オレフィン樹脂(1)の溶融物をストランド状に押出し、これを冷却後ペレット化した。
得られたペレットについて分析を行ったところ、水素化反応における水素添加率は99.8%、環状オレフィン樹脂(1)の重量平均分子量(Mw)は34,000、ガラス転移温度(Tg)は135℃、比重は1.01g/cm3、屈折率は、1.5345であった。
窒素置換した反応容器に、脱水n-ヘキサン456.1mL及び脱水塩化ブチル656.5mLを入れ、反応容器を-70℃に冷却した後、反応容器内に、イソブチレンモノマー196mL(2425mmol)、p-ジクミルクロライド0.929g(4.0mmol)、N,N-ジメチルアセトアミド1.22g(14mmol)を加えた。次いで、反応容器内に、四塩化チタン8.67mL(79.1mmol)を加えて、全容を撹拌し、-70℃で重合反応を行った。
反応開始から1.5時間後、反応容器内に、-70℃に冷却したモノマー液〔スチレンモノマー124g(1194mmol)、n-ヘキサン23.9mL及び塩化ブチル34.3mL〕を添加した。次いで、モノマー液の添加から45分後に、反応容器内に約40mLのメタノールを加えて重合反応を停止させた。
反応液から溶剤等を減圧留去した後、残渣をトルエンに溶解した。得られたトルエン溶液を、2回水洗した後、トルエン溶液を多量のメタノールに加えることで、重合体〔スチレン系熱可塑性エラストマー(1)〕を析出させた後、これをろ取し、60℃で24時間真空乾燥した。
スチレン系熱可塑性エラストマー(1)の重量平均分子量(Mw)は、70,000、スチレンブロックとイソブチレンブロックの割合は重量比で33:67、屈折率は、1.5350であった。
製造例2において、p-ジクミルクロライドの添加量を1.63g(7.0mmol)に変更したことを除き、製造例2と同様にしてスチレン系熱可塑性エラストマー(2)を得た。
スチレン系熱可塑性エラストマー(2)の重量平均分子量(Mw)は、40,000、スチレンブロックとイソブチレンブロックの割合は重量比で33:67、屈折率は、1.5343であった。
製造例2において、p-ジクミルクロライドの添加量を4.33g(19mmol)に変更したことを除き、製造例2と同様にしてスチレン系熱可塑性エラストマー(3)を得た。
スチレン系熱可塑性エラストマー(3)の重量平均分子量(Mw)は、15,000、スチレンブロックとイソブチレンブロックの割合は重量比で33:67、屈折率は、1.5341であった。
製造例2において、p-ジクミルクロライドの添加量を0.325g(1.4mmol)に変更したことを除き、製造例2と同様にしてスチレン系熱可塑性エラストマー(4)を得た。
スチレン系熱可塑性エラストマー(4)の重量平均分子量(Mw)は、200,000、スチレンブロックとイソブチレンブロックの割合は重量比で33:67、屈折率は、1.5340であった。
製造例1で得た環状オレフィン樹脂(1)90部、製造例2で得たスチレン系熱可塑性エラストマー(1)10部、酸化防止剤〔ペンタエリスリトールテトラキス[3-(3,5-ジ-t-ブチル-4-ヒドロキシフェニル)プロピオネート]〕0.5部、酸捕捉剤〔酸化マグネシウム〕0.3部を、ブレンダーで混合した後、70℃、0.1hPaで6時間、真空乾燥した。次いで、ホッパーを窒素置換した2軸混練機を用いて、270℃で混練した後、押出して、ペレット化した。
得られたペレットを用いて、樹脂温度265℃、型温度60℃で射出成形し、全長145.4mm、最大外形29.7mm、肉厚4.7mmのプリフォームを作成した。このプリフォームを、ブロー成形機(フロンティア社製、型式「EFB-1000ET」)にて、プリフォーム加熱温度178℃、ブロー時間2.10秒、サイクルタイム5.26秒の条件で、縦1.55倍、横2.00倍に延伸し、ブロー成形品を作製した。このブロー成形品を用いて、落下衝撃試験及び耐油性試験を行った。
また、前記ペレットを用いて、樹脂温度265℃、型温度120℃で射出成形し、光線透過率測定用試験片、シャルピー衝撃試験用試験片をそれぞれ作製し、各試験を行った。
実施例1において、環状オレフィン樹脂(1)の使用量を80部に、スチレン系熱可塑性エラストマー(1)の使用量を20部に変更したことを除き、実施例1と同様にしてペレット及び樹脂成形体を得、各試験を行った。
実施例1において、環状オレフィン樹脂(1)の使用量を70部に、スチレン系熱可塑性エラストマー(1)の使用量を30部に変更したことを除き、実施例1と同様にしてペレット及び樹脂成形体を得、各試験を行った。
実施例2において、スチレン系熱可塑性エラストマー(1)を、スチレン系熱可塑性エラストマー(2)を20部に変更したことを除き、実施例2と同様にしてペレット及び樹脂成形体を得、各試験を行った。
実施例1において、環状オレフィン樹脂(1)の使用量を99部に、スチレン系熱可塑性エラストマー(1)の使用量を1部に変更したことを除き、実施例1と同様にしてペレット及び樹脂成形体を得、各試験を行った。
実施例1において、環状オレフィン樹脂(1)の使用量を60部に、スチレン系熱可塑性エラストマー(1)の使用量を40部に変更したことを除き、実施例1と同様にしてペレット及び樹脂成形体を得、各試験を行った。
実施例2において、スチレン系熱可塑性エラストマー(1)を、スチレン系熱可塑性エラストマー(3)を20部に変更したことを除き、実施例2と同様にしてペレット及び樹脂成形体を得、各試験を行った。
実施例2において、スチレン系熱可塑性エラストマー(1)を、スチレン系熱可塑性エラストマー(4)を20部に変更したことを除き、実施例2と同様にしてペレットを得た。しかしながら、溶融粘度が大き過ぎるため、得られたペレットを用いて、目的の樹脂成形体を得ることはできなかった。
実施例1~4においては、ブロー成形法により、ボトル状の樹脂成形体が得られる。
また、このときに用いた樹脂組成物を用いて得られる樹脂成形体は、落下時に破損し難く、耐油性にも優れ、医療用途において特に好適に用いられる。
一方、比較例1、3の樹脂成形体は、落下時に破損し易く、耐油性に劣る。
比較例2の樹脂成形体は、透明性に劣り、医療用途においては適していない。
また、比較例4では、樹脂組成物の成形性に劣るため、目的の形状にブロー成形することができない。
Claims (3)
- 環状オレフィン樹脂、及び、スチレン系熱可塑性エラストマーを含有する樹脂組成物を成形して得られた樹脂成形体であって、
前記スチレン系熱可塑性エラストマーは、重量平均分子量(Mw)が20,000~150,000で、かつ、前記環状オレフィン樹脂の屈折率との屈折率の差(ΔnD)が-0.002超+0.002未満のものであり、
前記樹脂組成物を、日本薬局方に規定の強熱残分試験法に基づいて分析したときに、残分が0.10重量%以下、
前記樹脂組成物を、厚さが3.0mmのシート状に成形して、これを用いて光線透過率を測定したときに、波長が450nmの光の光線透過率(光路長3mm)が55%以上、かつ、
前記樹脂組成物を、厚さ4.0mm×長さ80.0mm×幅10.0mmの形状に成形して、これを用いてJIS K7111-1に規定されるノッチ付きシャルピー衝撃試験を23℃で行ったときに、シャルピー衝撃強さが5~40kJ/m2であることを特徴とする樹脂成形体。 - 前記スチレン系熱可塑性エラストマーが、スチレン系単量体由来の繰り返し単位からなるブロック(A)と、イソブチレン由来の繰り返し単位からなるブロック(B1)又は共役ジエン系単量体由来の繰り返し単位からなるブロック(B2)とを有するブロック共重合体、又はその水素化物である、請求項1に記載の樹脂成形体。
- 前記樹脂組成物中における、前記環状オレフィン樹脂とスチレン系熱可塑性エラストマーの含有量比が、重量比(環状オレフィン樹脂:スチレン系熱可塑性エラストマー)で、98:2~40:60である、請求項1又は2に記載の樹脂成形体。
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP15828229.3A EP3176217B1 (en) | 2014-07-28 | 2015-07-23 | Resin molded article |
JP2016538311A JPWO2016017528A1 (ja) | 2014-07-28 | 2015-07-23 | 樹脂成形体 |
US15/329,015 US20170218191A1 (en) | 2014-07-28 | 2015-07-23 | Resin molded article |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2014-152734 | 2014-07-28 | ||
JP2014152734 | 2014-07-28 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2016017528A1 true WO2016017528A1 (ja) | 2016-02-04 |
Family
ID=55217429
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/JP2015/071003 WO2016017528A1 (ja) | 2014-07-28 | 2015-07-23 | 樹脂成形体 |
Country Status (4)
Country | Link |
---|---|
US (1) | US20170218191A1 (ja) |
EP (1) | EP3176217B1 (ja) |
JP (1) | JPWO2016017528A1 (ja) |
WO (1) | WO2016017528A1 (ja) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2018047944A1 (ja) * | 2016-09-08 | 2018-03-15 | 三井化学株式会社 | 環状オレフィン系樹脂組成物および成形体 |
WO2019004333A1 (ja) * | 2017-06-30 | 2019-01-03 | Mcppイノベーション合同会社 | ビニル芳香族重合体成分を含む重合体、およびその製造方法 |
EP3604377A4 (en) * | 2017-03-21 | 2020-12-30 | Zeon Corporation | MOLDING COMPOUNDS, RESIN MOLDED BODIES, COSMETIC CONTAINERS, SEMICONDUCTOR CONTAINERS AND MANUFACTURING METHODS FOR SEMICONDUCTOR CONTAINERS |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US11649348B2 (en) | 2012-12-05 | 2023-05-16 | Zeon Corporation | Resin composition and medical drug container using same |
KR102541655B1 (ko) * | 2020-12-18 | 2023-06-14 | 미쯔비시 가스 케미칼 컴파니, 인코포레이티드 | 다층체 및 성형품 |
Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH1121413A (ja) * | 1997-07-02 | 1999-01-26 | Kanegafuchi Chem Ind Co Ltd | シクロオレフィン系共重合体樹脂組成物及びその製造方法 |
JP2004156048A (ja) * | 2004-02-09 | 2004-06-03 | Polyplastics Co | 環状オレフィン系樹脂組成物フィルム |
JP2011202085A (ja) * | 2010-03-26 | 2011-10-13 | Kaneka Corp | シクロオレフィン系共重合体樹脂組成物 |
JP2012172136A (ja) * | 2011-02-24 | 2012-09-10 | Riken Technos Corp | 熱可塑性エラストマー組成物 |
WO2013030944A1 (ja) * | 2011-08-30 | 2013-03-07 | 株式会社カネカ | シクロオレフィン系共重合体樹脂組成物 |
WO2014034200A1 (ja) * | 2012-08-31 | 2014-03-06 | ポリプラスチックス株式会社 | 透明フィルム |
WO2014087935A1 (ja) * | 2012-12-05 | 2014-06-12 | 日本ゼオン株式会社 | 樹脂組成物及びそれを用いた医療用薬剤容器 |
JP2015160399A (ja) * | 2014-02-28 | 2015-09-07 | 日本ゼオン株式会社 | 医療用成形体の製造方法 |
Family Cites Families (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5468803A (en) * | 1992-03-03 | 1995-11-21 | Nippon Zeon Co. Ltd. | Medical implement, polymer composition, and optical material |
JP3259476B2 (ja) * | 1993-09-30 | 2002-02-25 | 日本ゼオン株式会社 | シクロオレフィン系開環重合体水素添加物の製造方法 |
JP2003073460A (ja) * | 2001-08-31 | 2003-03-12 | Nippon Zeon Co Ltd | ノルボルネン系開環重合体水素添加物、その製造方法及びそれからなる成形体 |
EP1517162A1 (en) * | 2002-06-17 | 2005-03-23 | Zeon Corporation | Optical laminate, polarization light source device and liquid crystal display unit |
ATE552317T1 (de) * | 2003-12-19 | 2012-04-15 | Coloplast As | Klebmittel und damit ausgerüstete wundverbände und stomaartikel |
JP2005290231A (ja) * | 2004-03-31 | 2005-10-20 | Nippon Zeon Co Ltd | ノルボルネン系開環重合体及びその製造方法 |
CN101300308B (zh) * | 2005-11-11 | 2011-09-21 | 日立化成工业株式会社 | 树脂成形材料 |
JP5430858B2 (ja) * | 2007-02-01 | 2014-03-05 | 株式会社クラレ | 重合体組成物及びそれを用いて得られる成形体 |
JP5187214B2 (ja) * | 2009-02-10 | 2013-04-24 | 日立電線株式会社 | 発泡樹脂組成物及びこれを用いた電線・ケーブル |
JP2010266723A (ja) * | 2009-05-15 | 2010-11-25 | Nippon Zeon Co Ltd | 位相差フィルムの製造方法、位相差フィルム、円偏光フィルム、円偏光板、および液晶表示装置 |
JP5682321B2 (ja) * | 2010-09-28 | 2015-03-11 | 日本ゼオン株式会社 | ノルボルネン系開環共重合体水素化物及びその利用 |
JP2012097146A (ja) * | 2010-10-29 | 2012-05-24 | Kaneka Corp | シクロオレフィン系共重合体樹脂組成物 |
CN103201307B (zh) * | 2010-12-06 | 2015-05-13 | Jsr株式会社 | 环状烯烃开环聚合物、其氢化物及该氢化物组合物、以及三环戊二烯 |
JP2013056991A (ja) * | 2011-09-08 | 2013-03-28 | Nippon Zeon Co Ltd | 樹脂組成物、及びそれからなる成形体 |
JP5834880B2 (ja) * | 2011-12-19 | 2015-12-24 | コニカミノルタ株式会社 | 偏光板およびこれを用いた液晶表示装置 |
JP5942539B2 (ja) * | 2012-03-29 | 2016-06-29 | 日本ゼオン株式会社 | 光学用樹脂組成物 |
-
2015
- 2015-07-23 EP EP15828229.3A patent/EP3176217B1/en active Active
- 2015-07-23 JP JP2016538311A patent/JPWO2016017528A1/ja active Pending
- 2015-07-23 US US15/329,015 patent/US20170218191A1/en not_active Abandoned
- 2015-07-23 WO PCT/JP2015/071003 patent/WO2016017528A1/ja active Application Filing
Patent Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH1121413A (ja) * | 1997-07-02 | 1999-01-26 | Kanegafuchi Chem Ind Co Ltd | シクロオレフィン系共重合体樹脂組成物及びその製造方法 |
JP2004156048A (ja) * | 2004-02-09 | 2004-06-03 | Polyplastics Co | 環状オレフィン系樹脂組成物フィルム |
JP2011202085A (ja) * | 2010-03-26 | 2011-10-13 | Kaneka Corp | シクロオレフィン系共重合体樹脂組成物 |
JP2012172136A (ja) * | 2011-02-24 | 2012-09-10 | Riken Technos Corp | 熱可塑性エラストマー組成物 |
WO2013030944A1 (ja) * | 2011-08-30 | 2013-03-07 | 株式会社カネカ | シクロオレフィン系共重合体樹脂組成物 |
WO2014034200A1 (ja) * | 2012-08-31 | 2014-03-06 | ポリプラスチックス株式会社 | 透明フィルム |
WO2014087935A1 (ja) * | 2012-12-05 | 2014-06-12 | 日本ゼオン株式会社 | 樹脂組成物及びそれを用いた医療用薬剤容器 |
JP2015160399A (ja) * | 2014-02-28 | 2015-09-07 | 日本ゼオン株式会社 | 医療用成形体の製造方法 |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2018047944A1 (ja) * | 2016-09-08 | 2018-03-15 | 三井化学株式会社 | 環状オレフィン系樹脂組成物および成形体 |
JPWO2018047944A1 (ja) * | 2016-09-08 | 2019-02-21 | 三井化学株式会社 | 環状オレフィン系樹脂組成物および成形体 |
EP3604377A4 (en) * | 2017-03-21 | 2020-12-30 | Zeon Corporation | MOLDING COMPOUNDS, RESIN MOLDED BODIES, COSMETIC CONTAINERS, SEMICONDUCTOR CONTAINERS AND MANUFACTURING METHODS FOR SEMICONDUCTOR CONTAINERS |
WO2019004333A1 (ja) * | 2017-06-30 | 2019-01-03 | Mcppイノベーション合同会社 | ビニル芳香族重合体成分を含む重合体、およびその製造方法 |
Also Published As
Publication number | Publication date |
---|---|
US20170218191A1 (en) | 2017-08-03 |
EP3176217A1 (en) | 2017-06-07 |
EP3176217B1 (en) | 2019-12-04 |
EP3176217A4 (en) | 2018-03-28 |
JPWO2016017528A1 (ja) | 2017-04-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2016017528A1 (ja) | 樹脂成形体 | |
JP6347213B2 (ja) | 樹脂組成物及びそれを用いた医療用薬剤容器 | |
US11905380B2 (en) | Method for producing shaping material | |
JP2016155327A (ja) | 樹脂製容器の製造方法および樹脂製容器 | |
JP6708202B2 (ja) | 樹脂組成物および樹脂成形体 | |
JP5807644B2 (ja) | 樹脂組成物および樹脂成形体 | |
JP5682321B2 (ja) | ノルボルネン系開環共重合体水素化物及びその利用 | |
JP6763373B2 (ja) | 共重合体、重合体、成形材料及び樹脂成形体 | |
JPWO2017199980A1 (ja) | 水素化重合体、成形材料および樹脂成形体 | |
JP6809138B2 (ja) | 樹脂組成物及び樹脂成形体 | |
JPWO2018030105A1 (ja) | 樹脂組成物及び樹脂成形体 | |
JP6364814B2 (ja) | 医療用成形体の製造方法 | |
US11325287B2 (en) | Shaping material, resin shaped product, cosmetic container, semiconductor container, and method of producing semiconductor container | |
JP2018053150A (ja) | 樹脂成形体および樹脂成形体の製造方法 | |
JP2014148635A (ja) | 樹脂組成物及びその利用 | |
JP2016008302A (ja) | 樹脂組成物、および樹脂成形体 | |
JP2016069448A (ja) | 樹脂組成物、樹脂成形体、および光学部材 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 15828229 Country of ref document: EP Kind code of ref document: A1 |
|
ENP | Entry into the national phase |
Ref document number: 2016538311 Country of ref document: JP Kind code of ref document: A |
|
WWE | Wipo information: entry into national phase |
Ref document number: 15329015 Country of ref document: US |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
REEP | Request for entry into the european phase |
Ref document number: 2015828229 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2015828229 Country of ref document: EP |